In 2003, at the request of the Directorate General Enterprise of the European Commission, the EMA published a guidance document on the use of medicinal products for the treatment and prophylaxis of intoxication in patients exposed to chemical agents that might be used as weapons in terrorist or warfare actions.
The aim of the document was to give an overview of current expert opinion and recommendations on the use of medicines for the treatment of patients exposed to chemical agents. In 2024 the guidance was updated after a review of the scientific literature and existing guidelines and a consultation with a panel of European experts in toxicology, pharmacology, clinical management, and military aspects related to chemical agents and other toxic chemicals…
